vaccine manufacturing with single-use technology: an evaluation of process economy
Published 5 years ago • 730 plays • Length 33:58Download video MP4
Download video MP3
Similar videos
-
1:01
custom single use for biotech and vaccine manufacturing #biotechnology #pharma #vaccinedevelopment
-
51:56
how single-use technology is meeting the demand for commercial biologics manufacturing
-
42:12
accelerating vaccine production with non viral cell engineering
-
48:09
implementation of single use fermentation technology
-
42:18
single-use technology and sustainability: quantifying the environmental impact
-
9:52
single use technology in manufacturing of biologics
-
40:20
advances and challenges in vaccine development and manufacture
-
39:22
accelerating vaccine development by innovative purification solutions....
-
![an automated, closed system for rapid manufacturing of engineered t cells [webinar]](https://i.ytimg.com/vi/Y-FbSQQ7Ym4/mqdefault.jpg)
31:49
an automated, closed system for rapid manufacturing of engineered t cells [webinar]
-
1:03:11
biopharmaceutical process development – trends/ challenges/opportunities
-
31:11
mrna: removing bottlenecks in process development and manufacturing
-
1:15:17
developing practical single-use processes for new vaccine formulations
-
18:18
advanced materials for single-use biomanufacturing systems
-
59:44
flexible biopharma manufacturing now 7 24 14 2 00 pm
-
2:13
biopharmaceutical manufacturers can achieve more flexibility with single-use technologies
-
1:06:17
development and manufacturing of recombinant nanoparticle vaccines
-
1:25:22
science behind vaccines: australia’s capacity for large scale fermentation production of biologics
-
6:41
single-use technology in biomanufacturing - jean-marc cappia, sartorius stedim biotech
-
29:00
rapid mrna manufacturing for vaccine development
-
0:50
single-use technology & the implementation in biopharma // insights
-
1:30:11
advance the manufacturing of covid-19 vaccines and other health techonologies
-
1:33:02
local production of covid 19 vaccines: a collective capabilities approach